Cart
sales@molnova.com
Tabersonine
CAS No. 4429-63-4
Tabersonine( (–)-Tabersonine )
Catalog No. M14511 CAS No. 4429-63-4
Tabersonineis a terpene indole alkaloid found in the medicinal plantCatharanthus roseus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 69 | In Stock |
|
| 10MG | 97 | In Stock |
|
| 25MG | 161 | In Stock |
|
| 50MG | 239 | In Stock |
|
| 100MG | 356 | In Stock |
|
| 500MG | 844 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTabersonine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTabersonineis a terpene indole alkaloid found in the medicinal plantCatharanthus roseus.
-
DescriptionTabersonineis a terpene indole alkaloid found in the medicinal plantCatharanthus roseus.
-
In Vitro——
-
In Vivo——
-
Synonyms(–)-Tabersonine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number4429-63-4
-
Formula Weight336.43
-
Molecular FormulaC21H24N2O2
-
Purity>98% (HPLC)
-
SolubilitySoluble in Chloroform
-
SMILESCC[C@]1(C=CC(N2CC[C@@]34[C@@]21[H])=O)CC(C(OC)=O)=C4NC5=C3C=CC(OC)=C5
-
Chemical NameMethyl (5alpha,19alpha)-16-methoxy-8-oxo-2,3,6,7-tetradehydroaspidospermidine-3-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CAY10781
CAY10781 is an inhibitor of the protein-protein interaction between neuropilin-1 (NRP-1) and VEGF-A.1It inhibits the interaction by 43% when used at a concentration of 12.5 μM. CAY10781 also inhibits VEGF-A-induced phosphorylation of VEGFR2 in catecholamine A-differentiated (CAD) cells when used at the same concentration.
-
AZ876
AZ876 is a potent highly selective LXR agonist with Ki/EC50 of 7/6 nM and 11/73 nM for hLXRα and hLXRβ respectively.
-
Beta-Sitosterol
β-Sitosterol has recently been shown to induce G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways.
